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Abstract
A significant consequence of ischemia/reperfusion (I/R) is mitochondrial respiratory dysfunction, leading to energetic
deficits and cellular toxicity from reactive oxygen species (ROS). Mammalian complex I, a NADH-quinone
oxidoreductase enzyme, is a multiple subunit enzyme that oxidizes NADH and pumps protons across the inner
membrane. Damage to complex I leads to superoxide production which further damages complex I as well as other
proteins, lipids and mtDNA. The yeast, S. cerevisiae, expresses internal rotenone insensitive NADH-quinone
oxidoreductase (Ndi1); a single 56kDa polypeptide which, like the multi-subunit mammalian complex I, serves as
the entry site of electrons to the respiratory chain, but without proton pumping. Heterologous expression of Ndi1 in
mammalian cells results in protein localization to the inner mitochondrial membrane which can function in parallel
with endogenous complex I to oxidize NADH and pass electrons to ubiquinone. Expression of Ndi1 in HL-1
cardiomyocytes and in neonatal rat ventricular myocytes protected the cells from simulated ischemia/reperfusion (sI/R),
accompanied by lower ROS production, and preservation of ATP levels and NAD+/NADH ratios. We next generated a
fusion protein of Ndi1 and the 11aa protein transduction domain from HIV TAT. TAT-Ndi1 entered cardiomyocytes and
localized to mitochondrial membranes. Furthermore, TAT-Ndi1 introduced into Langendorff-perfused rat hearts also
localized to mitochondria. Perfusion of TAT-Ndi1 before 30 min no-flow ischemia and up to 2 hr reperfusion
suppressed ROS production and preserved ATP stores. Importantly, TAT-Ndi1 infused before ischemia reduced infarct
size by 62%; TAT-Ndi1 infused at the onset of reperfusion was equally cardioprotective. These results indicate that
restoring NADH oxidation and electron flow at reperfusion can profoundly ameliorate reperfusion injury.
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Introduction
Mammalian NADH-quinone oxidoreductase (complex I) is a
900kDa mitochondrial enzyme made up of at least 45 individual
subunits [1]. It is responsible for the oxidation of NADH,
contributes to the formation of the proton gradient which drives
ATP synthesis, and passes electrons to ubiquinone in the
respiratory chain [2]. Heritable disorders involving complex I
include myopathies, Parkinson’s Disease, Mitochondrial enceph-
alopathy with lactic acidosis and stroke-like syndrome (MELAS),
and Leber’s hereditary optic neuropathy (LHON) [3]. Ischemia/
reperfusion (I/R) injury is characterized by decreased complex I
respiration [4] and increased formation of reactive oxygen
species (ROS) [5,6], which in turn induce further damage to
complex I, lipids, mtDNA, mitochondrial proteins and other
cellular targets. ROS-induced ROS release can trigger cata-
strophic opening of the mitochondrial permeability transition
pore (mPTP) [7].
In bacteria and fungi, the enzymatic function of mammalian
complex I is carried out by structurally simpler enzymes,
collectively named NDH-2, which oxidize NADH and act as the
entry site of electrons to the respiratory chain [8,9]. The S. cerevisiae
mitochondrial NADH-quinone internal oxidoreductase (Ndi1), a
single polypeptide enzyme, oxidizes NADH and transfers electrons
to ubiquinone, but unlike complex I, it does not pump protons
across the inner membrane. Located on the matrix side of the
inner mitochondrial membrane, Ndi1 is a 513aa, 56kDa protein
containing a noncovalently bound FAD. Ndi1 is insensitive to
complex I inhibitors rotenone and 1-methyl-4-phenylpyridium ion
(MPP
+) but is sensitive to inhibition by flavone [9–11]. Much
interest has arisen in the ability to complement dysfunctional
mammalian complex I with Ndi1 or related enzymes from other
simple organisms.
Previous work by Yagi et al. showed that Ndi1 could be
expressed in human cells and could function in parallel with
complex I [12,13]. Ndi1 expression was sufficient to restore
respiratory activity in complex I deficient Chinese hamster
CCL16-B2 cells [14] and to protect against neurodegeneration
in an MPTP-induced mouse model of Parkinson disease [15]. In
the present study, we sought to determine whether Ndi1 delivered
by protein transduction could provide cardioprotection in in vitro
and ex vivo models of ischemia/reperfusion.
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Cloning
Construction of the mammalian expression vector pHook(Ndi1)
has been previously described [14] and was a generous gift from
Akemi and Takao Yagi (The Scripps Research Institute, La Jolla,
CA). To create TAT-Ndi1, the full length NDI1 insert was
amplified using 5-GCTTGGTACCAGTTTCATCAC-3 (KpnI site
italicized) and 5-GGCGAATTCTCAAGCATCATTTCG-3 (to gener-
ate a new EcoR1 site, italicized). This product was inserted into
the 6xHis-TAT-HA cloning vector (pTAT-HA, where HA is
hemagglutinin) kindly provided by Dr. Steven Dowdy (UCSD, La
Jolla, CA). Both the TAT and HA epitope are located N-terminal
to the insert which contains a 26aa N-terminal mitochondrial
targeting sequence original to yeast S. cerevisiae.
Cell culture and sI/R
The HL-1 cardiomyocyte line (generous gift of W. Claycomb)
was maintained in Claycomb media as previously described [16].
Cells were co-transfected with pHook-Ndi1 and mitochondrially
targeted DsRed (pDsRed2-mito, Clontech, Mountain View, CA)
and then subjected to simulated ischemia and reperfusion (sI/R).
Neonatal rat ventricular cardiomyocytes (NRVM) were prepared
as previously described [17] and plated on gelatin-coated dishes.
Transient lipid-based transfection of plasmid DNA was performed
using Effectene transfection reagent (Qiagen) per manufacturer’s
recommendation. NRVM and HL-1 cells were transfected at 60%
confluency and used 48 hr later. sI/R was performed by buffer
exchange from Krebs-Henseleit (KH, in mM: 110 NaCl, 4.7 KCl,
1.2 KH2PO4, 1.25 MgSO4, 1.2 CaCl2, 25 NaHCO3, 15 glucose,
20 HEPES, pH 7.4) to ischemia-mimetic solution (in mM: 125
NaCl, 8 KCl, 1.2 KH2PO4, 1.25 MgSO4, 1.2 CaCl2, 6.25
NaHCO3, 5 Na-lactate, 20 HEPES, pH 6.6) and placing the
dishes in hypoxic pouches (GasPak
TM EZ, BD Biosciences). After
2 hr, reperfusion was initiated by return to room air and buffer
exchange to normoxic Krebs–Henseleit solution. Controls incu-
bated in normoxic KH solution were run in parallel for each
condition and showed no loss of cell viability. Cell death was
scored by Yo-Pro-1 (Molecular Probes) staining (a marker for loss
of membrane integrity) and imaged by fluorescence microscopy.
Greater than 200 cells were scored per condition for cell death
assay and each experiment was performed at least three times. To
detect ROS production, CM-H2DCFDA (10mM, Invitrogen) was
added to cells grown in 96-well plates and incubated for 30 min.
Quantification was done by fluorescence plate reader (excitation/
emission 490/520nm). Isolation of adult rat cardiomyocytes was
performed as previously described [18]. Briefly, rat hearts were
perfused with heart media (10mM HEPES, 30mM taurine, 2mM
carnitine, 2mM creatine in JMEM) for 4 min at 3 ml/min and
then digested with digestion buffer (1 mg/ml of collagenase II,
6.25 mM CaCl2 in 50 ml perfusion buffer) for 18 min at 3 ml/
min. The heart was then removed and minced in digestion buffer,
to which stop buffer (perfusion buffer containing 12.5 mM CaCl2
and 5% newborn calf serum) was added. Cells were allowed to
sediment by gravity for 8–10 min in a 50-ml Falcon tube. The
supernatant was removed, and the pellet was resuspended in 30 ml
of room temperature stop buffer. Calcium was then reintroduced
to myocytes gradually to achieve a concentration of 1 mM, while
being monitored by microscopy. Rod-shaped myocytes (100,000
per 2 ml) were plated in laminin-coated 35-mm dishes and
allowed to recover overnight. Where indicated, TAT-Ndi1 was
transduced into adult myocytes or NRVMs by addition to media
at 500nM and incubated 20 min prior to sI/R treatment. TAT
protein was removed with buffer exchange. Adult cardiomyocytes
were subjected to 2 hours simulated ischemia and 2 hours
reperfusion as described above.
Preparation of heart lysates
Frozen heart samples were thawed on ice in homogenization
buffer (In mM: 50 Tris-HCl pH 7.4, 1 EDTA, 1 EGTA, 150
NaCl, 1 PMSF, 0.01 leupeptin, 0.01 E-64, and 1% Triton-X 100)
[40]. The tissue was minced and Polytron homogenized
(Kinematica, Basel, Switzerland) at 0uC with 3 pulses of 5 sec
each. The homogenates were centrifuged at 3,0006g for 10 min at
4uC to remove nuclei and cell debris. The supernatant, designated
as heart homogenate, was aliquotted and stored at 280uC until
use.
Preparation of isolated mitochondria
Hearts were rapidly excised and ventricles were minced and
homogenized twice by polytron for 2.5 sec in ice-cold mitochon-
drial isolation buffer (MIB, in mM: 10 MOPS pH 7.4, 250
sucrose, 5 KH2PO4, 2 MgCl2, 1 EGTA, 0.1% essentially fatty
acid-free BSA). Lysates were centrifuged twice for 5 min at 6006g
to remove unbroken tissue and nuclei and the supernatants were
centrifuged for 10 min at 3,0006g to pellet mitochondria. The
crude mitochondrial pellet was resuspended in swelling buffer
(MIB without BSA supplemented with 5 mM EGTA, 5 mM
pyruvate, and 5 mM malate).
Preparation of submitochondrial fractions
Crude mitochondria (prepared as above) were resuspended in
20 mM Hepes/PBS with fresh protease inhibitors and sonicated
for three cycles of 10 seconds each, then centrifuged at 120,0006g
for 3 hours at 4uC. The supernatant, containing the soluble
mitochondrial proteins, was concentrated using a Microcon IM-10
spin column (Millipore, Billirica, MA). The membrane pellet was
washed in 20 mM Hepes/PBS and centrifugation repeated. The
final membrane pellet was resuspended in homogenization buffer
containing 1% Triton-X 100 (as above).
Mitochondrial swelling assay
60 mg of isolated mitochondria were suspended in 200mL
swelling buffer in a 96-well plate. Where indicated, TAT-Ndi1
(500nM) or flavone (0.5mM) were added and Ca
2+ (250 mM) was
used to induce swelling. Absorbance was monitored in a plate
reader at 520 nm for 45 min at room temp.
Mitochondrial Respiration
200mg mitochondria were added to KCl respiration buffer (In
mM: 140 KCl, 10 MgCl2, 10 MOPS pH 7.4, 5 KH2PO4,1
EGTA, 0.2% essentially fatty acid-free BSA). Oxygen consump-
tion was recorded polarographically at 25uC using a Clark-type
oxygen mini-electrode (Hansateck, UK) in a water-jacketed
reaction chamber. Palmitoyl-L-carnitine (40mM), malate
(2.5mM), ADP (1mM), rotenone (0.5mM), and flavone (50mM)
were added to respiration chamber sequentially at indicated time
points.
Western blot analysis
Proteins prepared from rat hearts and cultured cells were
quantified by Bio-Rad protein assay. For immunodetection, 50 mg
of heart lysate prepared as above was resolved on SDS-PAGE 10–
20% denaturing gels and transferred to PVDF nylon membranes.
The membranes were blocked with 5% nonfat dry milk in 16
TBST buffer (100mM NaCl, 10mM Tris-HCl (pH 7.4), and 0.1%
Tween-20) for 1 hr, then incubated with 500-fold diluted
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overnight, washed with TBST buffer at room temp, and incubated
with goat anti-mouse horseradish peroxidase-conjugated second-
ary antibody (1:2000 dilution). Immunoreactive bands were
visualized by chemiluminescence (Super Signal West Dura
Substrate, Pierce). Each immunoblotting experiment was repeated
three times unless otherwise indicated and the results were
averaged.
Langendorff perfusion
Isolated rat hearts were perfused in Langendorff mode as
previously described [19,20]. In brief, after anesthesia and
heparinization (pentobarbital sodium 60 mg/kg i.p. and heparin
500 U i.p.), rat hearts were excised into ice-cold Krebs-Ringer
buffer (KRB) and within 30s were retrograde perfused via the aorta
with oxygenated buffer. Hearts were allowed to stabilize at constant
pressure (60 mm Hg) 20 min prior to I/R and where indicated,
TAT-Ndi1 (500 nM) was added to the perfusion buffer for 15 min
before ischemia or at the onset of reperfusion. Global no-flow
ischemia was maintained for 30 min and reperfusion was
accomplished by restoring flow with oxygenated buffer for 15 min
(for all measurements except infarct size determination). CK release
was quantified with the CK EC 2.7.3.2 UV test kit (Stanbio Lab,
Boerne, TX). In brief, the coronary elute was collected from the first
15 min of reperfusion, pooled and 1mL aliquots were used for
analysis according to manufacturer’s recommendations. Ongoing
production of superoxide in heart slices after the perfusion protocol
was quantified by measuring ethidium fluorescence derived from
oxidation of dihydroethidium as described [21,22]. Relative ATP
levels were quantified by luminescent plate reader using Cell Titer
Glo kit as recommended (Promega, Madison, WI). Lipid peroxi-
dation was determined by measuring malondialdehyde (MDA) and
4-hydroxyalkenals (HAE) levels according to manufacturer’s
instructions (Oxford Biomed, Oxford, MI). NAD+/NADH ratios
were determined by colorimetric plate reader assay per manufac-
turer’s specifications (Biovision Inc., San Francisco, CA). Biochem-
ical analyses of ischemic and reperfused heart tissue were performed
on hearts quick-frozen in liquid nitrogen. Infarct size determination
by triphenyl tetrazolium chloride (TTC) staining was performed on
hearts reperfused for 120 min [23]. 2mm tissue sections were
stained and a minimum of 5 sections per heart were analyzed.
Volume analysis of infarct size was performed using Adobe
Photoshop (Adobe Systems, San Jose, CA). All procedures were
approved by the Animal Care and Use Committee at San Diego
State University and conform to the Guide for the Care and Use of
Laboratory Animals (National Institutes of Health publication no. 85-
23, revised 1996).
TAT-mediated protein transduction
Recombinant protein expression and purification was per-
formed as described [24]. Briefly, a 2mL LB-ampicillin (100 mg/
ml) culture of bacteria transformed with pTAT-Ndi1 was grown at
37uC and 225 rpm for 5 hours and transferred to a 100mL
overnight culture until it reached an OD600 of 0.9–1.2. The
overnight culture was diluted into a final volume of 1 L of fresh
LB-ampicillin and incubated to an OD600 of 0.6–0.9. Isopro-
pylthiogalactoside (IPTG, Roche) was added to the culture and
incubated for an additional 10 hours at 130 rpm, 35uC. The
bacterial pellet was harvested by centrifugation at 6000 rpm for
10 min at 4uC and resuspended in 15 mL of cold PBS. This was
repeated and the final pellet dissolved in 15 mL buffer Z (8 M
urea, 100 mM NaCl, and 20 mM Hepes, pH 8.0) plus 10mM
imidazole. The lysate was sonicated on ice (3 pulses of 40 s)
followed by centrifugation at 16,000 rpm for 30 min at 4uC. 7 mL
of supernatant was applied to a 25 mL column packed with 6 mL
of Ni-NTA resin (Qiagen) equilibrated in buffer Z plus 10 mM
imidazole, rocked at 4uC overnight. The flow-through was
collected by gravity flow and re-applied to the column twice.
The column was washed with 50 mL of buffer Z and proteins were
eluted in 17 mL buffer Z containing 250 mM imidazole followed
by another elution with 17 mL buffer Z containing 1 M imidazole.
Both elution fractions were pooled and concentrated to half the
volume using an Amicon Ultra centrifugation device (Millipore).
Immediately prior to use, 2.5 mL of eluate was desalted on a PD-
10 column (GE Healthcare), equilibrated in PBS +10% glycerol
and eluted with 3.5mL. TAT-Ndi1 was diluted into Krebs-Ringer
Buffer (500nM final concentration). TAT-mediated protein
transduction provides significantly higher efficiency, nearly 100%
in cell culture, as compared to lipid-based transient transfection
which has ,40% efficiency; TAT-proteins allow for tissue-
transduction as well. We previously showed that TAT-b-
galactosidase control protein had no effect on heart function or
infarct size [25–27], therefore, we did not include a TAT-b-gal
control protein in the present studies.
Widefield fluorescence microscopy
Cells and tissues were observed through a Nikon TE300
fluorescence microscope (Nikon) equipped with a 46 lens and a
206 lens (0.3NA, Nikon), a 606Plan Apo objective (1.3 NA oil
immersion lens; Nikon), a Z-motor (ProScanII, Prior Scientific), a
cooled CCD camera (Orca-ER, Hamamatsu) and automated
excitation and emission filter wheels controlled by a LAMBDA 10-
2 (Sutter Instrument) operated by MetaMorph 6.2r4 (Molecular
Devices Co.). Fluorescence was excited through an excitation filter
for FITC (HQ480/x40), Texas Red (D560/x40). Fluorescent light
was collected via a polychroic beamsplitter 8(61002 bs) and an
emission filter for fluorescein isothiocyanate (HQ535/50m), and
Texas Red (D630/60m). All filters were from Chroma. Acquired
wide field Z-stacks were routinely deconvolved using 10 iterations
of a 3D blind deconvolution by MetaMorph 6.2r4. Unless stated
otherwise, representative images shown are maximum projections
of Z-stacks taken with 0.20mm increments capturing total cellular
volume.
Statistical analysis
The probability of statistically significant differences between
two experimental groups was determined by both paired Student’s
t-test and ANOVA. Values are expressed as means 6 SD of at
least three independent experiments unless stated otherwise, and P
values are reported for ANOVA. A value of P,0.05 was
considered significant.
Results
Ndi1 localizes to mitochondria and prevents cell death
following simulated ischemia/reperfusion
To confirm Ndi1 localization, HL-1 cells were transiently co-
transfected with pHook(Ndi1) and pDsRed2-mito and Ndi1 was
detected by immunostaining for the HA tag. Ndi1 co-localized
with mito-DsRed with distinctive mitochondrial morphology
(Figure 1A). To determine the ability of Ndi1 to protect against
sI/R-induced cell death, transfected HL-1 cells and NRVMs were
subjected to 2 hour simulated ischemia and 24 hours reperfusion.
Expression of Ndi1 decreased cell death in HL-1 cells and
NRVMs (Figure 1B). Pretreatment with the Ndi1-inhibitor,
flavone, abolished cytoprotection in HL-1 cells subjected to sI/R
(Figure 1C), indicating protection against cell death was due to
Ndi1 activity.
Ndi1 in Myocardial Reperfusion Injury
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mitochondria
To explore the possibility that Ndi1 might be useful inthe context
of I/R, we generated a cell-permeable recombinant protein
consisting of full length Ndi1 fused to a hemagglutinin (HA) epitope
and the undecapeptide protein transduction domain (PTD) of HIV
TAT (TAT-Ndi1, Figure 2A). Adult rat cardiomyocytes were
transduced with TAT-Ndi1 (Figure 2B&C) and detected by
immunostaining for Ndi1. TAT-Ndi1 was detected in 100% of
cells and displayed a mitochondrial morphology in .75% of
myocytes, co-localizing with mitochondrial protein cytochrome c
within 1 min in HL-1 cells and adult cardiomyocytes (Figure 2C).
TAT-Ndi1 is protective against sI/R and remedies
energetic deficits and oxidative stress in cardiac cells
To confirm the cytoprotection results observed with transient
transfection, NRVMs exposed to TAT-Ndi1 were subjected to sI/
R. Cell death indicated by permeability to Yo-Pro-1 decreased from
30.0% to 8.1% in the presence of TAT-Ndi1 (Figure 3A). Oxidative
stress, reduced ATP synthesis, and failure to oxidize NADH are
results ofcomplex Idamageafterischemicinjury.DCFDAwasused
to measure H2O2 production in NRVMs subjected to sI/R. Ndi1
reduced ROS production by 51% (Figure 3B), and preserved ATP
levels after sI/R (Figure 3C). To detect mitochondrial damage in
adult cardiomyocytes subjected to sI/R with or without TAT-Ndi1,
cytochrome c release was monitored by immunofluorescence. 73%
of TAT-Ndi1 treated cells retained cytochrome c in mitochondria
compared to 17% of cardiomyocytes subjected to sI/R in the
absence of TAT-Ndi1 (Unt) (Figure 3D). Electron microscopy of
adult rat cardiomyocytes subjected to sI/R show a frequent loss of
defined mitochondrial crista structure, with only 48% of mitochon-
dria retaining detectable cristae. In cells transduced with TAT-
Ndi1, 89% of mitochondria have well-defined invaginations of the
cristae, comparable to control cells (no I/R) (Figure 3E, * indicates
absence of cristae).
TAT-Ndi1 localizes to mitochondria in Langendorff-
perfused rat hearts
To confirm localization and the ability to transduce TAT
protein by aortic perfusion, Langendorff-perfused rat hearts given
Figure 1. Ndi1-mediated cytoprotection following simulated ischemia reperfusion is specific. A. pHook(Ndi1) and pDsRed2-mito were
transiently transfected into HL-1 cells. Ndi1 (stained with anti-HA antibody) co-localized with mitochondria (DsRed-mito) (merged). B. Ndi1-
transfected and empty pHook-transfected HL-1 cells and neonatal rat cardiomyocytes were subjected to 2 hours simulated ischemia and 24 hours
reperfusion. Cell death was scored by permeability to Yo-Pro-1 stain and only transfected cells were scored. ($250 cells scored per experiment, n=3,
*p,0.05). C. Neonatal rat cardiomyocytes transfected with empty pHook or pHook(Ndi1) were subjected to 2 hours simulated ischemia and 24 hours
reperfusion. Pretreatment with Ndi1-inhibitor flavone abolished the cytoprotective effect of Ndi1 expression. Cell death was scored by permeability
to Yo-Pro-1 stain and only transfected cells were scored. ($250 cells scored per experiment, n=3, **p,0.005).
doi:10.1371/journal.pone.0016288.g001
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stained with antibodies to Ndi1 and complex IV. TAT-Ndi1 was
found in a striated pattern that co-localized with complex IV
(Figure 4A). Mitochondria isolated from Langendorff-perfused rat
hearts were subfractionated to generate membrane and soluble
protein fractions and probed for Ndi1 expression. TAT-Ndi1 was
only detected in the isolated mitochondrial membrane fraction
(Figure 4B).
TAT-Ndi1 overcomes complex I dysfunction due to I/R
injury
To determine the effect of TAT-Ndi1 on I/R-induced
energetic deficits and oxidative damage, we perfused rat hearts
with TAT-Ndi1 followed by global no-flow ischemia and 15 min
reperfusion. I/R results in a 50% reduction of ATP content, but
TAT-Ndi1 prevents ATP depletion (Figure 5A). Dihydroethi-
dium-stained sections of hearts subjected to I/R showed that
TAT-Ndi1 transduction reduced superoxide production
(Figure 5B) and lipid peroxidation (Figure 5C). Administration
of TAT-Ndi1 shifted the NAD+/NADH ratio towards NAD+
under basal conditions and following I/R. TAT-Ndi1 increased
the ratio 3-fold over I/R conditions without TAT-Ndi1
(Figure 5D).
Mitochondrial integrity and function is preserved by Ndi1
protein transduction
Mitochondrial integrity is compromised by I/R injury, often
leading to opening of the mitochondrial permeability transition
pore (MPTP) and release of pro-apoptotic factors culminating in
cell death. ROS generated from complex I are thought to trigger
MPTP opening. To determine if TAT-Ndi1 could prevent
mitochondrial swelling, hearts were perfused with TAT-Ndi1 or
vehicle, then mitochondria were isolated and induced to
undergo swelling with the addition of Ca
2+.T A T - N d i 1
attenuated swelling by 72%63.0 (slope) and 41%62.6 (Vmax)
(Figure 6A&B). This effect was abolished by inhibition of Ndi1
with flavone. Complex I-dependent respiration was reduced
from 66nmol/min/mg to 26nmol/min/mg after I/R, but
administration of Tat-Ndi1 increased malate/palmitoyl-L-carni-
tine-driven oxygen consumption to 40nmol/min/mg after I/R.
This improvement can be largely attributed to TAT-Ndi1-
dependent respiration, as the rotenone-insensitive rate is
10nmol/min/mg in the presence of TAT-Ndi1, with or without
I/R, confirming the functional incorporation of Ndi1 into the
respiratory chain. It is possible that Ndi1, through the reduction
of ROS levels, also helps to preserve a small amount of complex
I activity following I/R.
Figure 2. Generation of TAT-Ndi1 and expression in vitro.A . Map of TAT-Ndi1 construct generated from inserting full length NDI1 gene
(1,539bp) from pHook(NDI1) into the 6xHis-TAT-HA cloning vector. B. Lysates of adult rat ventricular myocytes were transduced with TAT-Ndi1 at
500nM in complete maintenance media for 20 min. Cell lysates were probed with anti-HA antibody to detect TAT-Ndi1. C. Adult cardiac myocytes
(first and second rows) and HL-1 cells (third row) were transduced with TAT-Ndi1 at 500nM for 1 or 15 min as indicated, fixed and double-labeled with
affinity-purified rabbit antibody to S. cerevisiae Ndi1 and mouse monoclonal cytochrome c antibody.
doi:10.1371/journal.pone.0016288.g002
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Given the ability of TAT-Ndi1 to overcome the effects of
complex I damage and preserve mitochondrial integrity, we wanted
to determine the capacity of Ndi1 to protect against I/R injury ex
vivo. Rat hearts were perfused 20 min with or without TAT-Ndi1
priorto30 minglobal no-flowischemiaand 2 hrreperfusion.TAT-
Ndi1 reduced infarct size by 62%68.1, based on TTC staining
(Figure 7A). Creatine kinase release was reduced by 51.6%63.02
following I/R in hearts perfused with TAT-Ndi1 (Figure 7B).
Ndi1 is protective against I/R injury when administered at
the onset of reperfusion
Much of the damage to mitochondria occurs during the early
minutes of reperfusion. To determine whether TAT-Ndi1 can
protect the heart if given at reperfusion, Ndi1 was added to
perfusion buffer at the onset of reperfusion after 30 min ischemia
and hearts were reperfused for 2 hours. TTC staining indicated
that infarct size was reduced by 58.2%64.2 when TAT-Ndi1 was
administered at reperfusion. This degree of protection is
comparable to that observed with pretreatment (Figure 7C).
Figure 3. TAT-Ndi1 protects against sI/R and remedies energetic deficits and oxidative stress in cardiac cells. A. Neonatal rat
cardiomyocytes transduced with 500nM TAT-Ndi1 for 20min were subjected to 2 hours simulated ischemia and 24 hours reperfusion. Cell death was
scored by permeability to Yo-Pro-1 stain relative to total cell number determined by Hoechst 33342 staining. ($250 cells scored per experiment, n=3,
*p,0.05). B. NRVMs were incubated 20 min with TAT-Ndi1 and subjected to 2 hours simulated ischemia and 24 hours reperfusion.
Dichlorodihydrofluorescein diacetate was used to measure ROS levels in cells following 2 hours simulated ischemia and 24 hours reperfusion.
(n=3, *p,0.05). C. ATP production in control and TAT-Ndi1 transduced NRVMs following 2 hours simulated ischemia and 24 hours reperfusion.
(n=3, ***p,0.0005). D. Cultured adult rat cardiac myocytes were incubated with TAT-Ndi1 and then subjected to 2 hours simulated ischemia and
2 hours reperfusion. Cytochrome c release was detected by mouse anti-cytochrome c antibody and cells with intact mitochondria quantified by
fluorescence. ($100 cells scored per experiment, n=3, *p,0.05). E. Adult rat cardiomyocytes incubated 20 min +/2 TAT-Ndi1 were subjected to
2 hours simulated ischemia and 2 hours reperfusion. EM images are representative of two separate experiments. Asterisks denote mitochondria
which have lost cristae architecture.
doi:10.1371/journal.pone.0016288.g003
Figure 4. TAT-Ndi1 localization in Langendorff-perfused rat heart. A. Cryosections of rat hearts perfused 20 min with TAT-Ndi1 or with
vehicle alone (+Veh). Heart sections were stained with rabbit antibody to Ndi1 (green), mouse monoclonal antibody specific for complex IV (red) and
Hoechst 33258 nuclear stain (blue). B. Hearts were perfused with or without 500nM TAT-Ndi1 for 20 min. Mitochondria were isolated and sonicated
to yield membrane and soluble fractions were separated and probed for Ndi1 (representative image).
doi:10.1371/journal.pone.0016288.g004
Ndi1 in Myocardial Reperfusion Injury
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Ischemia reperfusion injury in the heart is a leading cause of
morbidity in the western world. Complexes I, III, IV and V of the
respiratory chain and many Krebs cycle enzymes are compro-
mised by I/R injury [28–30]. Oxidative damage plays a central
role in cardiac dysfunction resulting from I/R, with maximal
generation of ROS and reactive nitrogen species occurring at the
onset of reperfusion. Complex I is particularly susceptible to
oxidative damage and subsequently produces more ROS [31],
leading to extensive mitochondrial dysfunction and the depletion
of ATP. Complex I dysfunction also impairs the oxidation of
NADH, which can lead to the production of superoxide radicals
through the FMN group of complex I and a-ketoglutarate
dehydrogenase [32]. ROS-induced ROS release leads to MPTP
with mitochondrial swelling, release of pro-apoptotic factors such
as cytochrome c and cell death via apoptosis and necrosis [33].
Thus, complex I plays a central role mediating I/R injury.
Bypassing damaged complex I with a single-subunit enzyme
that will oxidize NADH in the matrix addresses the accumulation
of NADH and the resulting oxidative damage. The expression of
Ndi1, the yeast alternate NADH-quinone oxidoreductase enzyme,
prevented cell death in both in vitro and ex vivo models of I/R,
demonstrating that I/R injury in the heart is tied to dysfunction of
complex I and oxidative damage. In order to deliver Ndi1 protein
to tissue, we generated a TAT-Ndi1 fusion protein capable of
entering cells and localizing to the mitochondrial matrix, where it
was able to transfer electrons from NADH to ubiquinone. We
show here that TAT-Ndi1 favors NADH oxidation following I/R,
confirming functional integration of the TAT protein into the host
respiratory chain. Maintenance of this redox potential confers
protection from oxidative stress and prevents transfer of electrons
from NADH to oxygen via damaged complex I.
In comparison to complex I, Ndi1 catalyzes a two-electron transfer
reaction that is believed to prevent the formation of an ubisemiqui-
none intermediate during the process of NADH oxidation [9,12].
This reaction mechanism minimizes electron leakage and the
subsequent formation of ROS. It has been demonstrated that
Ndi1-mediated NADH oxidation does not generate superoxide
radicals, in distinction to other NDH-2 enzymes and complex I/
Figure 5. TAT-Ndi1 overcomes effects of complex I dysfunction. A. ATP levels in rat heart tissue +/2 TAT-Ndi1 following 30 min ischemia and
15min reperfusion or without treatment (veh). TAT-Ndi1 prevents depletion of ATP stores in I/R hearts. (n=4, *p,0.05, ***p,0.0005). B.
Dihydroethidium stained 1mm rat heart sections +/2TAT-Ndi1 following 30 min no-flow ischemia and 15 min reperfusion. TAT-Ndi1 reduces
superoxide production following I/R (representative image, n=3). C. Total free MDA levels normalized to total protein in hearts perfused 20 min with
or without TAT-Ndi1 and subjected to 30 min ischemia and 15 min reperfusion or perfused constantly with vehicle (n=3, **p,0.005). D. NAD
+/
NADH ratios from rat hearts perfused 15 min +/2 TAT-Ndi1 then subjected to 30 min ischemia and 15 min reperfusion or perfused continuously with
vehicle (n=4, *p,0.05, **p,0.005).
doi:10.1371/journal.pone.0016288.g005
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peroxidation in cells subjected to sI/R and heart tissue following I/R.
Coupled with preventing ROS generation by complex I, likely
through maintaining a high redox potential (low matrix NADH/
NAD+ ratio) [35,36], Ndi1 is an effective combatant of oxidative
damage, especially under I/R conditions.
The cardioprotective effects of Ndi1 were robust, accompanied
by a significant reduction in oxidative damage. Preservation of ATP
levels was indirect, since Ndi1 does not pump protons and is likely a
reflectionoflesscelldeath.TheabilityofNdi1topreventcomplexI-
mediated ROS release rather than effects on ATP production was
the most likely mechanism of protection in combination with the
effects on the NAD
+/NADH ratio [36]. Other NAD
+/NADH-
dependent pathways may be directly or indirectly affected by Ndi1-
mediated oxidation of NADH under ischemic conditions. For
instance, aldehyde dehydrogenases require NAD
+ as a cofactor in
the metabolism of acetylaldehyde and other toxic aldehydes.
Mitochondrial aldehyde dehydrogenase (ALDH2) has been impli-
cated in cardioprotection from ischemic injury by both modulating
the autophagic pathway and through inhibiting formation of 4-
hydroxy-2-nonenal (4-HNE)-protein adducts [40]. It is possible that
TAT-Ndi1 helps to maintain ALDH2 activity, thereby reducing
toxicaldehydeformation.Caspase-independentapoptoticcelldeath
may also be attenuated by eliminating PARP activation by ROS
[41]. Sirtuins are NAD
+-dependent proteins implicated in defense
against aging, diabetes, stress and Alzheimer’s Disease. Although
sirtuins are regulated by the NAD
+/NADH ratio, overexpression of
Ndi1 in Drosophila did not increase Sir2 activity although fly
lifespanwasextendedby20–40%,an effectattributed todiminished
mitochondrial ROS production [42].
TAT-mediated protein transduction provides a novel and efficient
approach to address complex I deficiencies and is a burgeoning area
Figure 6. Mitochondrial integrity and function is preserved by TAT-Ndi1. A. The absorbance of cardiac mitochondrial suspension from rat
heart tissue was measured in the presence or absence of TAT-Ndi1. Hearts were perfused +/2 TAT-Ndi1 for 20 min prior to isolating mitochondria.
TAT-Ndi1 protects against calcium-induced mitochondrial swelling and this inhibition is abolished by Ndi1 inhibitor, flavone (representative trace,
n=4). B. Slope and Vmax of mitochondrial swelling are reduced in mitochondria with TAT-Ndi1 (n=4, p,0.05). C. Oxygen consumption of
mitochondria isolated from rat hearts with or without TAT-Ndi1 and subjected to I/R (I/R+TAT-Ndi1:double line, I/R alone: dashed line) or constantly
perfused (Con:thick line, +TAT-Ndi1:thin line). Oxygen levels were continuously monitored using a platinum Clark-type oxygen electrode. Changes of
O2 concentration in chamber are shown with administration of treatments indicated (n=4, representative trace). D. Rate of oxygen consumption
following addition of complex I substrates palmitoyl-L-carnitine/malate and ADP (1mM final) prior to (black bars) and following (grey bars) addition of
rotenone (*p,0.05). Mitochondria were isolated from hearts +/2 TAT-Ndi1 subjected to I/R or constantly perfused (control and Ndi1 alone).
doi:10.1371/journal.pone.0016288.g006
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TAT-fusion proteins and peptides have been used to promote cell
death in mouse cancer models including prostate, breast, leukemia,
melanoma, and glioma [37]. A TAT-fusion peptide inhibitor of
protein kinaseC delta(KAI-9803) showed promiseina clinical trialof
myocardial infarct size reduction [38]. Additional clinical trials are
underway for treatment of ischemic stroke and neurodegenerative
disease using KAI-9803 [39]. Effective replacement therapy for
complex I deficiencies and protection from I/R injury requires
efficient incorporation of the enzyme into the host respiratory chain.
Treatment of I/R injury, in particular, requires rapid incorporation
during the first minutes of reperfusion. We have shown that TAT-
Ndi1 functionally incorporated into host mitochondriaand conferred
cardioprotectionwhen administered either asa pretreatment or atthe
onset of reperfusion, indicating rapid protein transduction. This is the
first time functional delivery of a mitochondrial inner membrane-
targeted TAT protein has been demonstrated and our results show
that Ndi1 has significant protective effects on mitochondrial integrity
and overall oxidative state.
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